CPAPNEA Medical Supply
Letter data
- Company
- CPAPNEA Medical Supply
- Recipient
- Sal T. Hakim | Owner | CPAPNEA Medical Supply | 10443 N. Cave Creek Rd, #110 | Phoenix | , | AZ | 85020-1637 | United States | sal@cpapnea.com
- Issue date
- 2020-11-24
- Posted date
- Not available
- FDA office
- Office ofMedical Device and Radiological Health Operations Division 3West
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 592737
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
CPAPNEA Medical Supply
MARCS-CMS 592737 —
November 24, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Product:
Medical Devices
Recipient:
Recipient Name
Sal T. Hakim
Recipient Title
Owner
CPAPNEA Medical Supply
10443 N. Cave Creek Rd, #110
Phoenix
,
AZ
85020-1637
United States
sal@cpapnea.com
Issuing Office:
Office ofMedical Device and Radiological Health Operations Division 3West
United States
Dear Mr. Hakim:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter dated January 22, 2020. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Jessica Mu,
Director, Compliance Branch
Office of Medical Devices and
Radiological Health, Division III
Content current as of:
12/01/2020
Regulated Product(s)
Medical Devices